{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:30:49Z","timestamp":1791570649052,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.euo.2024.01.019","type":"journal-article","created":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T13:13:50Z","timestamp":1708780430000},"page":"1080-1087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Transperineal Versus Transrectal Magnetic Resonance Imaging\u2013targeted Biopsies for Prostate Cancer Diagnosis: Final Results of the Randomized PERFECT trial (CCAFU-PR1)"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6004-2152","authenticated-orcid":false,"given":"Guillaume","family":"Ploussard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Barret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Fiard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Lenfant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Malavaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Giannarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Almeras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Aziza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00eble","family":"Renard-Penna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Descotes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Rozet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Beauval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambroise","family":"Salin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2024.01.019_b0005","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/JU.0000000000001523","article-title":"Transperineal prostate biopsy improves the detection of clinically significant prostate cancer among men on active surveillance","volume":"205","author":"Meyer","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2024.01.019_b0010","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/bju.12536","article-title":"Sepsis and 'superbugs': should we favour the transperineal over the transrectal approach for prostate biopsy?","volume":"114","author":"Grummet","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2024.01.019_b0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12957-019-1573-0","article-title":"Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis","volume":"17","author":"Xiang","year":"2019","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.euo.2024.01.019_b0020","first-page":"1004","article-title":"Comparison of ultrasound-guided transrectal and transperineal prostate biopsies in clinical application","volume":"20","author":"Yuan","year":"2014","journal-title":"Zhonghua Nan Ke Xue"},{"key":"10.1016\/j.euo.2024.01.019_b0025","unstructured":"European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/quinolone-fluoroquinolone-containing-medicinal-products."},{"key":"10.1016\/j.euo.2024.01.019_b0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bju.15039","article-title":"Comparison of complications after transrectal and transperineal prostate biopsy: a national population-based study","volume":"126","author":"Berry","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2024.01.019_b0035","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1017\/S0950268815002885","article-title":"The global burden of major infectious complications following prostate biopsy","volume":"144","author":"Bennett","year":"2016","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.euo.2024.01.019_b0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/bju.15062","article-title":"The clinical and financial implications of a decade of prostate biopsies in the NHS: analysis of Hospital Episode Statistics data 2008\u20132019","volume":"126","author":"Tamhankar","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2024.01.019_b0045","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer\u20142020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.01.019_b0050","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/JU.0000000000001399","article-title":"Nonantibiotic strategies for the prevention of infectious complications following prostate biopsy: a systematic review and meta-analysis","volume":"205","author":"Pradere","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2024.01.019_b0055","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.euo.2024.01.019_b0060","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.eururo.2010.12.009","article-title":"Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting","volume":"59","author":"Dickinson","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.01.019_b0065","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.eururo.2013.03.030","article-title":"Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an international working group","volume":"64","author":"Moore","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.01.019_b0070","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/MOU.0000000000000415","article-title":"The role of the multiparametric MRI in the diagnosis of prostate cancer in biopsy-naive men","volume":"27","author":"Rhudd","year":"2017","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.euo.2024.01.019_b0075","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.euo.2020.12.012","article-title":"Magnetic resonance imaging\/ultrasound fusion-guided transperineal versus magnetic resonance imaging\/ultrasound fusion-guided transrectal prostate biopsy\u2014a systematic review","volume":"4","author":"Rai","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2024.01.019_b0080","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.euo.2023.08.001","article-title":"Is there an impact of transperineal versus transrectal MRI-targeted biopsy in clinical-significant prostate cancer detection rate? A systematic review and meta-analysis","volume":"6","author":"Uleri","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2024.01.019_b0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41391-020-0204-8","article-title":"\u201cTREXIT 2020\u201d: why the time to abandon transrectal prostate biopsy starts now","volume":"23","author":"Grummet","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euo.2024.01.019_b0090","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.euros.2022.09.007","article-title":"Clinical trial protocol for PERFECT: a randomised controlled trial comparing the efficiency and tolerance of transperineal fusion versus transrectal imaging-targeted prostate biopsies (CCAFU-PR1 Study)","volume":"45","author":"Touzani","year":"2022","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euo.2024.01.019_b0095","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euo.2024.01.019_b0100","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","article-title":"Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study","volume":"20","author":"Rouviere","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euo.2024.01.019_b0105","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S1473-3099(22)00373-5","article-title":"Antibiotic prophylaxis versus no antibiotic prophylaxis in transperineal prostate biopsies (NORAPP): a randomised, open-label, non-inferiority trial","volume":"22","author":"Jacewicz","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.euo.2024.01.019_b0110","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/JU.0000000000002802","volume":"208","author":"Zattoni","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2024.01.019_b0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/bju.14017","article-title":"Prospective comparison of transperineal magnetic resonance imaging\/ultrasonography fusion biopsy and transrectal systematic biopsy in biopsy-na\u00efve patients","volume":"121","author":"Borkowetz","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2024.01.019_b0120","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.21873\/anticanres.15244","article-title":"Cancer detection rates in targeted transperineal MRI-TRUS elastic fusion-guided prostate biopsies performed under local anesthesia","volume":"41","author":"Jacewicz","year":"2021","journal-title":"Anticancer Res"},{"key":"10.1016\/j.euo.2024.01.019_b0125","doi-asserted-by":"crossref","unstructured":"Hu JC, Assel M, Allaf ME, et al. Transperineal versus transrectal magnetic resonance imaging-targeted and systematic prostate biopsy to prevent infectious complications: the PREVENT randomized trial. Eur Urol. In press. https:\/\/doi.org\/10.1016\/j.eururo.2023.12.015.","DOI":"10.1016\/j.eururo.2023.12.015"},{"key":"10.1016\/j.euo.2024.01.019_b0130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2022.01.008","article-title":"Targeted prostate biopsy: umbra, penumbra, and value of perilesional sampling","volume":"82","author":"Brisbane","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.01.019_b0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.eururo.2019.04.008","article-title":"Role of core number and location in targeted magnetic resonance imaging-ultrasound fusion prostate biopsy","volume":"76","author":"Lu","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.01.019_b0140","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/jcm9010225","article-title":"Assessment of the minimal targeted biopsy core number per MRI lesion for improving prostate cancer grading prediction","volume":"9","author":"Ploussard","year":"2020","journal-title":"J Clin Med"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258893112400049X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258893112400049X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T23:35:24Z","timestamp":1727220924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258893112400049X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S258893112400049X"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2024.01.019","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transperineal Versus Transrectal Magnetic Resonance Imaging\u2013targeted Biopsies for Prostate Cancer Diagnosis: Final Results of the Randomized PERFECT trial (CCAFU-PR1)","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2024.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}